Mata-Marín, José A <br/><br/>
APRI as a predictor of early viral response in chronic hepatitis C patients.  [electronic resource] 

 -  World journal of gastroenterology  Oct 2009 
 - 4923-7 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.15.4923  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Aspartate Aminotransferases--blood<br/>Case-Control Studies<br/>Clinical Enzyme Tests<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Platelet Count<br/>Polyethylene Glycols--therapeutic use<br/>Predictive Value of Tests<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult